NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

Remembering William A. Anders

June 20, 2024, 7:01AMNuclear News

William A. Anders, former chairman of the Nuclear Regulatory Commission and a former member of the American Nuclear Society, died on June 7 at 90 years of age.In a June 18 statement, the NRC...